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Summary
Pathogens often have a limited host range, but some can
opportunistically jump to new species. Anthropogenic activ-
ities that mix reservoir species with novel, hence suscep-
tible, species [1] can provide opportunities for pathogens
to spread beyond their normal host range. Furthermore,
rapid evolution can produce new pathogens bymechanisms
such as genetic recombination [2]. Zoos unintentionally
provide pathogens with a high diversity of species from
different continents and habitats assembled within a
confined space. Institutions alert to the problem of pathogen
spread to unexpected hosts can monitor the emergence of
pathogens and take preventative measures [3]. However,
asymptomatic infections can result in the causative patho-
gens remaining undetected in their reservoir host. Further-
more, pathogen spread to unexpected hosts may remain
undiagnosed if the outcome of infection is limited, as in
the case of compromised fertility, or if more severe
outcomes are restricted to less charismatic species that
prompt only limited investigation. We illustrate this problem
here with a recombinant zebra herpesvirus infecting charis-
matic species including zoo polar bears over at least four
years. The virus may cause fatal encephalitis and infects at
least five mammalian orders, apparently without requiring
direct contact with infected animals [4–8].Results
Virus Identification
In June 2010, two cohoused polar bears (Ursus maritimus),
a threatened species, suffered epileptiform seizures at the
Zoological Gardens Wuppertal, Germany. The 20-year-old
female, Jerka, presented symptoms first and died 8 days after
the onset of clinical signs (see Movie S1 available online).
Necropsy indicated moderate to severe nonsuppurative
encephalitis and gliosis of unknown etiology as the cause of
death. The perivascularly accentuated inflammation consisted
of lymphocytes and plasma cells. The lesions were consistent
with virus infection, but inclusion bodies that are associated
with some viral pathogens, including herpesviruses, were not
identified. The 16-year-old male, Lars, survived after medical5These authors contributed equally to this work
*Correspondence: greenwood@izw-berlin.deintervention, which included intravenous administration of
a hypertonic electrolyte solution and diazepam to prevent
seizures (Movie S1). It took several weeks for him to fully
recover.
Faced with many potential causative agents, we applied
PCR targeting eight plausible encephalitis pathogens (Experi-
mental Procedures) and high-throughput DNA microarrays
(ViroChip) to extracted DNA and RNA from Jerka’s brain [9].
The ViroChip can test for the presence of several thousand
known DNA and RNA viral sequences in a single assay but is
biased toward human viruses and is less sensitive than other
methods such as PCR or deep sequencing [10, 11]. PCR is
very sensitive but prone to false negatives if the sequence
targeted by the primers does not match perfectly. The only
pathogen detected in Jerka was a virus related to equid
herpesvirus 1 (EHV1) [12]) identified by quantitative PCR. Addi-
tional PCR assays and the ViroChip did not detect other
candidate pathogens (Table 1). Western blot analysis using
antibodies against the EHV1 IR6 protein [13] supported the
finding of herpesvirus nucleic acids and demonstrated protein
expression exclusively in Jerka’s brain (Figure 1; Supple-
mental Experimental Procedures).
Virus Phylogenetics
Equid herpesvirus 9 (EHV9), a virus thought to have originated
in the plains zebra (Equus burchelli) and that is closely related
to EHV1, has been known to cause fatal encephalitis in polar
bears [14, 15]. EHV1 related to domestic horse strains has
also been shown to cause fatal encephalitis in black bears
(Ursus americanus) [8]. To determine the identity of the viral
strain from Jerka, we sequenced portions of six genes, namely
UL49.5, 484 bp;UL45, 667 bp; gC (UL44), 1,523 bp; Pol (UL30),
810 bp; gB (UL27), 1,140 bp; and IR6, 342 bp, and phylogenet-
ically compared the obtained sequences to known EHV1,
EHV9, andmore distantly related EHV4 sequences (alignments
available in the Supplemental Data Sets). All amplicons were
directly sequenced and cloned into standard plasmid vectors.
Multiple individual clones per amplicon were also sequenced
to confirm the sequences obtained from direct sequencing.
The sequencing analyses provided no evidence for coinfection
with more than one EHV strain.
Jerka’s sequences clustered with horse (Equus caballus)
EHV1 strains but were divergent (1%–3%) at the nucleotide
level and formed a sister lineage for the UL49.5, gC (UL44),
Pol (UL30), and IR6 genes (Figure 2A). The UL45 and gB
(UL27) gene sequences and part of Pol (UL30) were nearly
identical to a distinct EHV1 strain of plains zebras, designated
here as zebra EHV1, which is clearly different from the strain
that caused fatalities in black bears (Figure 2A, UL45 tree)
[6]. The remaining genes that we sequenced from Jerka have
not been determined for the zebra EHV1 strain. Many of the
substitutions were nonsynonymous and changed amino acid
sequences when compared to the reference horse EHV1 strain
Ab4 (Table S1). Zebra EHV1 is widespread in zoo zebras and is
known to infect and cause encephalitis in four other orders of
mammals following experimental inoculation or after natural
infection in zoos (Figure 2) [4–7].
Surprisingly, the Pol (UL30) gene was a recombinant
between EHV1 and EHV9, with the 50 portion of the amplicon
being EHV1-like, the middle being EHV9-like, and the last
Table 1. Serological and qPCR Results for the Eleven Polar Bears in This
Study
Polar Bear Sample EHV1 Diagnostic Result
Jerka blooda SNT <1:4
brain qPCR gB Ct 30.2
brain qPCR gC Ct 31.5
brain PCR DNA sequences
brain western blot IR6 positive
liver western blot IR6 negative
Lars serum SNT <1:4
feces qPCR gB Ct 38.5
feces qPCR gC Ct 39
saliva qPCR gB Ct 38
saliva qPCR gC Ct 37.4
Struppo serum SNT 1:16
brain qPCR gB negative
brain qPCR gC negative
brain western blot IR6 negative
blood PCR DNA sequences
Knut blooda SNT <1:4
brain qPCR gB negative
brain qPCR gC negative
Anton serum SNT <1:4
blood qPCR gB negative
blood qPCR gC negative
Sonja serum SNT <1:4
brain qPCR gB negative
brain qPCR gC negative
brain western blot IR6 negative
Felix serum SNT <1:4
Anuschka serum SNT <1:4
Nanuk serum SNT <1:4
Anastasia serum SNT <1:4
Anja serum SNT <1:4
Serum neutralization test (SNT) and quantitative PCR (qPCR) results are
indicated for each bear. The two bears from which DNA sequences were
obtained are also indicated. qPCR results are shown as threshold cycle
(Ct) values with the number provided. Brain qPCR results are based on
200 ng of extracted DNA; feces and saliva qPCR results are based on
DNA extracted from 16.6 ml of swabs.
aSNT from Jerka and Knut performed from blood as serum could not be
isolated.
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Figure 1. Detection of EHV1 IR6 Gene Product from Polar Bear Tissue
Samples
Samples were homogenized and lysed in RIPA buffer. The lysates were
separated by 12% SDS-PAGE, transferred to polyvinylidene fluoride
membranes, and analyzed by western blot using an IR6-specific antibody
[13]. Lysates of RK13 cells infected with EHV1 Ab4 strain were included
as a positive control. Primary rabbit anti-IR6 polyclonal antibody was
used at a dilution of 1:10,000, followed by goat anti-rabbit IgG conjugated
with horseradish peroxidase. The arrow indicates the IR6 gene product
detected in Jerka’s brain (lane 2) but not in other tissues (liver, lane 1) or
other bears (Struppo, lane 3; Sonja, lane 4).
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1728110 bp again being EHV1-like (Figures 2B and S1B; Experi-
mental Procedures). As a consequence, Jerka’s sequences
showed variable affinity to EHV1 and EHV9 as a function of
the portion of Pol (UL30) sequenced (Figure S1A). Although
the second recombination breakpoint within Pol (UL30) did
not reach statistical significance, the sequences downstream
of position 700 in Pol (UL30) and sequences upstream and
downstream of Pol (UL30) clustered exclusively with EHV1,
including gB (UL27) found in close proximity on the genome
(Figure 2). Thus, both recombination breakpoints are probably
within thePol (UL30) gene itself. Although amixture of two EHV
strains, the complete 810 bp amplicon sequence showed
a stronger overall phylogenetic affinity with EHV1 [Figure 2A,
Pol (UL30) tree], results consistent with the sequence analyses
of other genes that also point to EHV1 as themost likely candi-
date agent for the clinical condition seen in Jerka.The Distribution of Zebra EHV1 in Zoo Polar Bears
To assess the overall prevalence of the identified virus in our
collection of captive polar bear samples, we performed serum
neutralization tests against EHV1 and quantitative PCR on
samples from 11 unrelated polar bears from five different
zoos (Table 1). Including Jerka and Lars, 3 of 11 (27%) of thebears were positive, with recent samples tested from Lars
being at the limit of detection (Table 1; Experimental Proce-
dures). Sequencing a 184 bp Pol (UL30) fragment from the
blood of an asymptomatic seropositive bear, Struppo, who
died from glomerulonephritis in 2006 and was never cohoused
with Jerka or Lars, showed that he was infected with a zebra
EHV1 identical to Jerka’s for the portion sequenced (Fig-
ure S1A). In the case of Jerka, the virus was only detected in
brain and was associated with acute lethal infection. Struppo
was only positive in blood, suggesting that the route of infec-
tion may have been different.Discussion
Zebra EHV1 likely caused Jerka’s death within 8 days, may
have sickened Lars, and independently infected Struppo
asymptomatically four years earlier in another zoo. Struppo
was never cohoused with either Jerka or Lars, and thus the
infections are almost certainly independent events. Intensive
and expensive high-throughput methods were required to
identify one pathogen and rule out many others. Zebra EHV1
represents the second EHV associated with fatality in captive
polar bears. EHV9, which may also be a zebra-derived virus,
has also been associated with captive polar bear fatalities
[14, 15]. Such distantly related hosts are unexpected for
herpesviruses, which typically are highly adapted to one
particular host. In fact, among the closest relatives of EHV1
and EHV9 in the genus Varicellovirus, only pseudorabies virus,
a pathogen of pigs that causes morbidity and mortality in
bovines and domestic cats and dogs, is known to have jumped
to other species under natural conditions [16, 17]. Our phylo-
genetic analyses suggest that the virus we detected in the
polar bears originated in zebras, where zebra EHV1 recom-
bined with EHV9. It remains unclear what the frequency of
infection of zebras with EHV1 and EHV9 is in captivity. Such
information, however, is critical for the appropriate epidemio-
logical management of polar bears and other threatened
species in captivity.
Recombination is not uncommon for herpesviruses, but it
usually does not result in the acquisition of new hosts. It is
unclear at present where the recombination occurred,
Figure 2. Phylogeny of Polar Bear EHV1
(A) Results of the phylogenetic analysis of polar bear EHV sequences. The schematic of the EHV genome is shown in the middle of the figure indicating rela-
tive gene positions designated by their UL numberwhere applicable. IR6 is repeated twice, but we found no evidence for differences between the two copies
in our sequence data. An estimated phylogeny is shown for each gene sequenced. Each database-extracted sequence is denoted by GenBank accession
number, species from which the sequence was isolated, and viral strain, separated by underscores. Polar bear sequences from this study and an EHV9
sequence determined previously [15] are highlighted in red. Sequences derived from domesticated and wild horse are in blue, giraffe (Giraffa camelopar-
dalis) in orange, guinea pig (Cavia porcellus) in purple, antelope (Antilope cervicapra) and gazelles (Eudorcas thomsoni) in green, and black bear (Ursus
americanus) in black. Node support is indicated by black semicircles for >90% support or white semicircles for <90% (but not <50%) support. At each
node of interest, the left semicircle represents the posterior probability, and the right semicircle represents the maximum-likelihood bootstrap support.
The Pol (UL30) phylogenetic tree is highlighted and connected to (B) to indicate its further recombination analysis.
(B) Detection of recombination between EHV1 and EHV9 in the Pol (UL30) gene. EHV1-like sequences are in white, and EHV9-like sequences are shaded
gray. The diagram at top indicates that the genes upstream and downstream of Pol (UL30) show greatest affinity to EHV1, whereas Pol (UL30) varies in
its affinity across the sequence determined in this study. The middle part of the figure demonstrates that within Pol (UL30), the first 80 bp amplified
show a strong phylogenetic affinity to EHV1, whereas positions 81–699 demonstrate affinity to EHV9. Positions 700–810 show greatest affinity to EHV1,
although they contained only six phylogenetically informative sites. As a consequence, only the recombination breakpoint at position 80 was statistically
significant (see Experimental Procedures and Figure S2 for the phylogenetic analysis on which the trees in the figure are based). No statistically significant
result for a second breakpoint was obtained, as indicated by the red question mark. However, the phylogenetic affinity of the final 110 bp sequenced was to
EHV1, and all sequences downstream of Pol (UL30) were more closely related to EHV1 than to EHV9, suggesting that the second breakpoint is contained
within Pol (UL30). Posterior probabilities and likelihood bootstrap support are shown at each node. The bottom of the figure shows the nucleotide differ-
ences of the polar bear sequence relative to EHV9 and reference EHV1 strain Ab4. Identical sequences are represented by dots, and differences are indi-
cated by the base substitution relative to polar bear.
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1729although we surmise it could have occurred in African-born or
zoo zebras. Similarly unclear is whether the newly recombined
virus has a broadened host range and/or greater pathogenic
potential. The latter is a distinct possibility because
Pol (UL30) is one factor that determines neurovirulence of
EHV1 in horses [18, 19], and recombination of EHV1 and
EHV9, identified in polar bears, was within Pol (UL30). Thefindings suggest that Pol (UL30) may play an important role
in the outcome of infection of nonequine species as well. It is
noteworthy that EHV1 infections of nonequine species, such
as llamas and alpacas, can have devastating neurological
consequences characterized by involvement of a variety of
cell types and that often result in death [20]. Whereas two of
the polar bears, Jerka and Lars, developed acute neurological
Current Biology Vol 22 No 18
1730symptoms consistent with observations in nonequids,
Struppo remained asymptomatic, and zebra EHV1 was de-
tected in blood and not brain in his case. We speculate that
these different manifestations and disease outcomes are
a result of different routes of virus entry or virus dose. Jerka
and Lars could have been infected directly with large amounts
of virus via the conjunctiva and eye or the olfactory nerve,
whereas Struppo may have encountered lower doses of virus
via a different route in the periphery.
The mode and source of transmission of the newly discov-
ered recombinant virus remain unknown, however. The polar
bear enclosure where Jerka and Lars were housed is 68 m
away from the zebra enclosure and 340 m from the guinea
pig enclosure (another species susceptible to zebra EHV1).
The polar bear caretakers were also responsible for guinea
pigs in the Zoological Gardens Wuppertal at the time of the
outbreak. It is conceivable, therefore, that personnel may
present a mode of transmission, as might the ubiquitous
presence of rodents in zoos that could be responsible for
transmission of the infection from one enclosure to the next.
Future research will consider the epidemiology of zebra
EHV1 in the captive zebra population and in other species
with known and unknown susceptibility to zebra EHV1.
In conclusion, we find that the zebra EHV1 strain reported
here may critically threaten zoo animals because of its
apparent temporal and geographical spread in the zoo bear
population and its ability to infect a wide range of taxa. The
recombinant strain apparently spreads without obvious or
known direct contact between infected animals. Because its
mode of transmission is unknown, control will be difficult.
Asymptomatic infection of one bear with the recombinant
zebra virus suggests that the host range might be even
broader than described. The threat that the virus poses is
particularly acute because several zebra species are wide-
spread in zoo collections and because the closely related
EHV9 has also jumped to polar bears. EHV9 is also associated
with fatality in polar bears [14, 15] and other ubiquitous zoo
species such as gazelles [21], which might become new reser-
voirs and facilitate transmission of viruses. Our analysis rein-
forces the potential of zoos for disease outbreak monitoring
[3, 21] and indicates that the spread of opportunistic and
potentially deadly pathogens among captive, nonsympatric
threatened species can endanger the conservation mission
of zoos.
Experimental Procedures
ViroChip and Pathogen PCRs
Polar bear samples examined in this study are described in the Supple-
mental Experimental Procedures and Table S1. The ViroChip is a DNA
microarray used to detect known viruses and to discover newly emerging
ones [10, 22]. The microarray has oligonucleotides representing all known
viral classes. ViroChip analysis was performed essentially as previously
described [11]. It should be noted that few EHV1- or EHV9-related oligonu-
cleotides are present on this array system, and sensitivity is far lower than
PCR or deep sequencing methods [11]. The method is a general screen,
but not sensitive enough to definitively exclude pathogen presence in
a sample, especially if it is highly underrepresented relative to host DNA
or if there are mismatches between sequences in the sample and those
on the chip. Experimental details are provided in the Supplemental Experi-
mental Procedures.
PCRs for specific encephalitis-causing pathogens were carried out on
DNA or RNA depending on the viral genome using primers for bornavirus
[23], adenovirus [24], West Nile virus [25, 26], tick-borne encephalitis [27],
rabies [28], parvovirus [29], and canine distemper virus [30, 31] as described
in the cited references, with the exception that MyTaq HS from Bioline was
used. In the rare cases where a PCR product was detected, such as forcanine distemper virus, the product was Sanger sequenced (StarSEQ,
Mainz, Germany) with the forward and reverse primers used in the PCR.
None of the sequences was of viral origin. PCRs for EHV1 are described
in detail in the Supplemental Experimental Procedures.
EHV1 Serum Neutralization Assay
Serum neutralization assays were performed as described in the OIE
Manual of Diagnostic Tests and Vaccines for Terrestrial Animals [32], with
minor modifications. Sera were inactivated for 30 min at 56C, and 25 ml of
sera was diluted with an identical volume of minimal essential medium
(MEM) supplemented with 5% fetal bovine serum (FBS). Duplicates of
the sera were diluted in 96-well plates in log2 steps in MEM-FBS before
addition of 100 tissue culture infectious doses 50% (TCID50) per well of
EHV1 strain RacL11 in 25 ml of MEM-FBS. Plates were incubated at 37C
for 60 min before addition of 5 3 104 RK13 cells in a total volume of
100 ml. Cytopathic effects were assessed after 5 days of incubation at
37Cby crystal violet staining. A negative control serum (titer < 4) and a posi-
tive control serum (titer = 512) were included in each plate. The titer of each
serum was determined as the reciprocal of the highest dilution at which
the monolayer was intact in both duplicate wells. Plates were included in
the assessment only when negative and positive control sera showed the
expected values. Results for the 11 bears tested in this study are shown
in Table 1.
Recombination and Phylogenetic Analyses
Recombination analysis was conducted using the distance-based method
implemented in Recombination Analysis Tool 1.0 [33]. The size of the sliding
window was set to 10% of the alignment length, with increments of half this
length. In order to improve estimates of genetic distances between pairs of
sequences, GenBank sequenceswith extensivemissing datawere removed
prior to recombination analysis.
Phylogenetic analysis of each gene was conducted using maximum-
likelihood and Bayesian methods. Substitution models were selected using
the Bayesian information criterion. Maximum-likelihood analyses were
conducted with MEGA 5 [34] using a heuristic search with the nearest-
neighbor-interchange algorithm. Phylogenetic support was estimated using
1,000 bootstrap replicates.
Bayesian phylogenetic analysis of each gene was performed using
MrBayes 3.2 [35]. Posterior estimates of parameters, including the tree
topology, were obtained using Markov chain Monte Carlo (MCMC)
sampling. Samples were drawn every 2,000 steps over a total of 20 million
MCMC steps, with the first 10% of steps discarded as burn-in. Two
independent runs were performed, each with one cold and three heated
chains. Sufficient sampling from the stationary distribution was checked
by inspecting the standard deviation of split frequencies, and additional
MCMC simulations were conducted where necessary.
Accession Numbers
Polar bear sequences determined in this study were deposited in GenBank
with accession numbers JQ692311–JQ692316.
Supplemental Information
Supplemental Information includes one figure, one table, Supplemental
Experimental Procedures, Supplemental Data Sets, and one movie and
can be found with this article online at http://dx.doi.org/10.1016/j.cub.
2012.07.035.
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